(Q39019030)

8 September 2017

title

GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity (English)

1 reference

8 September 2017

1 reference

neoplastic invasiveness

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Maurizio Memo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

PierFranco Spano

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Chiara Fiorentini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Serena Bodei

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Francesca Bedussi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Martina Fragni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Claudio Simeone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Danilo Zani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Alfredo Berruti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Cristina Missale

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Sandra Sigala

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

28 February 2014

1 reference

Experimental Cell Research

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

100-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589892%20AND%20SRC:MED&resulttype=core&format=json

Pathologic basis of focal therapy for early-stage prostate cancer

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Molecular states underlying androgen receptor activation: a framework for therapeutics targeting androgen signaling in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Changing therapeutic paradigms in castrate-resistant prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Lineage dependency and lineage-survival oncogenes in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Dysregulated expression of growth factors and their receptors in the development of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Nerve growth factor signaling in prostate health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Nerve growth factor induces the re-expression of functional androgen receptors and p75(NGFR) in the androgen-insensitive prostate cancer cell line DU145.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Functional roles of osteoactivin in normal and disease processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, l-amino acid-defined diet, accelerates motility of hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Osteoactivin promotes breast cancer metastasis to bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

MMP inhibition in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

MMP-9 overexpression due to TIMP-1 and RECK underexpression is associated with prognosis in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Overexpression of MMP-9 contributes to invasiveness of prostate cancer cell line LNCaP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

A fluorescence vital assay for the recognition and quantification of excitotoxic cell death by necrosis and apoptosis using confocal microscopy on neurons in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Control of matrix metalloproteinase activity in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Tissue inhibitors of metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Non-Small-Cell Lung Cancer Molecular Signatures Recapitulate Lung Developmental Pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Molecular characterisation of soft tissue tumours: a gene expression study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Nerve growth factor suppresses the transforming phenotype of human prolactinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Nerve growth factor and retinoic acid inhibit proliferation and invasion in thyroid tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Loss of low-affinity nerve growth factor receptor during malignant transformation of the human prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Expression of p75NTR in a human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

The p75NTR mediates a bifurcated signal transduction cascade through the NF kappa B and JNK pathways to inhibit cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

PROMO: detection of known transcription regulatory elements using species-tailored searches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Temporal association of the N- and O-linked glycosylation events and their implication in the polarized sorting of intestinal brush border sucrase-isomaltase, aminopeptidase N, and dipeptidyl peptidase IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Human metastatic prostate PC3 cell lines degrade bone using matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Study of matrix metalloproteinases and their inhibitors in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Gpnmb/osteoactivin, an attractive target in cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025

Overexpression of matrix metalloproteinase 11 in Thai prostatic adenocarcinoma is associated with poor survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.02.025